ELI LILLY & Co
For the period ended Sep 30, 2025. Filed Oct 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 30, 2025
LLY$1,432.29+1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Condensed Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash Flows from Operating Activities | ||
| Net income | $14,002.3 | $6,180.2 |
| Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: | ||
| Depreciation and amortization | 1,411.3 | 1,281.8 |
| Change in deferred income taxes | (958.9) | (1,716.4) |
| Stock-based compensation expense | 489.9 | 503.7 |
| Acquired in-process research and development | 2,381.2 | 3,091.2 |
| Other changes in operating assets and liabilities, net of acquisitions | (4,418.9) | (3,160.1) |
| Other operating activities, net | 681.5 | 163.7 |
| Net Cash Provided by Operating Activities | 13,588.4 | 6,344.1 |
| Cash Flows from Investing Activities | ||
| Purchases of property and equipment | (5,294.3) | (3,561.8) |
| Proceeds from sales of and distributions from noncurrent investments | 832.0 | 318.0 |
| Purchases of noncurrent investments | (518.0) | (525.1) |
| Cash paid for acquisitions, net of cash acquired | (549.4) | (947.7) |
| Purchases of in-process research and development | (2,584.3) | (3,094.6) |
| Other investing activities, net | (55.8) | 430.2 |
| Net Cash Used for Investing Activities | (8,169.8) | (7,381.0) |
| Cash Flows from Financing Activities | ||
| Dividends paid | (4,038.5) | (3,512.1) |
| Net change in short-term borrowings | (4,337.6) | (4,894.1) |
| Proceeds from issuance of long-term debt | 13,167.2 | 11,417.1 |
| Repayments of long-term debt | (778.1) | (664.2) |
| Purchases of common stock | (2,600.3) | (446.1) |
| Other financing activities, net | (746.9) | (445.1) |
| Net Cash Provided by Financing Activities | 665.8 | 1,455.5 |
| Effect of exchange rate changes on cash and cash equivalents | 439.1 | 131.8 |
| Net increase in cash and cash equivalents | 6,523.5 | 550.4 |
| Cash and cash equivalents at January 1 | 3,268.4 | 2,818.6 |
| Cash and Cash Equivalents at September 30 | $9,791.9 | $3,369.0 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.